The use of botulinum toxin in patients with sialorrhea

Operative Techniques in Otolaryngology - Head and Neck Surgery

Volumn 19, Issue 4, 2008, Pages 243-247

  Bhayani, Mihir K ^a   Suskind, Dana L ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Botox; Botulinum toxin; Drooling; Neurologic dysfunction; Parotid; Sialorrhea; Submandibular

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ANESTHESIA INDUCTION; ARTICLE; CHILD CARE; CLINICAL PROTOCOL; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDICATION; DYSPHAGIA; ECHOGRAPHY; FOLLOW UP; HUMAN; HYPERSALIVATION; INJECTION SITE HEMATOMA; PAROTID GLAND; PRIORITY JOURNAL; SEDATION; SUBMANDIBULAR GLAND; TOPICAL ANESTHESIA; XEROSTOMIA;

EID: 57349153894     PISSN: 10431810     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otot.2008.10.008     Document Type: Article

References (35)

1. Mier R.J., Bacrach S.J., Lakin R.C., et al. Treatment of sialorrhea with glycopyrrolate. Arch Pediatric Adolesc Med 154 (2000) 1214-1218
2. Van de Heyning P.H., Marquet J.F., and Creten W.C. Drooling in children with cerebral palsy. Acta Otorhinolaryngol Belg 34 (1980) 691-705
3. Pal P.K., Calne D.B., Calne S., et al. Botulinum toxin A as treatment for drooling saliva in Parkinson's disease. Neurology 54 (2000) 244-247
4. Torres M.A., Aytes L.B., and Escoda C.G. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Pathol Oral Cir Buccal 12 (2007) E511-E517
5. Porta M., Gamba M., Bertacchi G., et al. Treatment of sialorrhea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 70 (2001) 538-540
6. Jongerius P.H., van den Hoogen F.J.A., van Limbeek J., et al. Effect of botulinum toxin in the treatment of drooling: A controlled clinical trial. Pediatrics 114 (2004) 620-627
7. Martin T.J., and Conley S.F. Long-term efficacy of intra-oral surgery for sialorrhea. Otolaryngology-Head and Neck Surg 137 (2007) 54-58
8. Klem C., and Mair E.A. Four-duct ligation: A simple and effective treatment for chronic aspiration from sialorrhea. Arch Otolaryngol Head Neck Surg 125 (1999) 796-800
9. Stern Y., Feinmesser R., Collins M., et al. Bilateral submandibular gland excision with parotid duct ligation for treatment of sialorrhea in children. Arch Otolaryngol Head Neck Surg 128 (2002) 801-803
10. Shaari C.M., Wu B.L., Biller H.F., et al. Botulinum toxin reduces salivation from canine submandibular glands. Otolaryngol Head Neck Surg 118 (1998) 452-457
11. Daniel SJ. Botulinum toxin A injection for the treatment of severe sialorrhea or aspiration in children under the age of 5 years. Scientific presentation. American Society of Pediatric Otolaryngology Annual Meeting. Orlando, FL, May 4, 2008
12. Blitzer A., and Sulica L. Botulinum toxin: Basic science and clinical uses in otolaryngology. Laryngoscope 111 (2001) 218-226
13. Eckardt A., and Kuettner C. Treatment of gustatory sweating (Frey's Syndrome) with botulinum toxin A. Head Neck 25 (2003) 624-628
14. Ellies M., Laskawi R., Rohrbach-Volland S., et al. Botulinum toxin to reduce salivary flow: Selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope 112 (2002) 82-86
15. Suskind D.L., and Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 112 (2002) 73-81
16. Chow T.L., Chan S.W., and Lam S.H. Ranula successfully treated by botulinum toxin type A: Report of 3 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105 (2008) 41-42
17. Banerjee K.J., and O'Flaherty S.J. Parotid and submandibular botulinum toxin a injections for sialorrhea in children with cerebral palsy. Dev Med Child Neuro 48 (2006) 883-887
18. Lipp A., Trottenburg T., Schink T., Kupsch A., et al. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 61 (2003) 1279-1281
19. Tintner R., Gross R., Winzer U.F., et al. Autonomic function after botulinum toxin type A or B: A double blind randomized trial. Neurology 65 (2005) 765-767
20. Racette B.A., Good L., Sagitto S., et al. Botulinum toxin B reduces sialorrhea in Parkinsonism. Mov Disord 18 (2003) 1059-1061
21. Contarino M.F., Pompili M., Tittoto P., et al. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. Parkinsonism Relat Disord 13 (2007) 299-303
22. Ondo W.G., Hunter C., and Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 62 (2004) 37-40
23. Berweck S., Schroeder A.S., Lee S.H., et al. Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands. Dev Med Child Neurol 49 (2007) 62-64
24. Dressler D., and Eleopra R. Clinical use of non-A botulinum toxins: botulinum toxin type B. Neurotox Res 9 (2006) 121-125
25. Blitzer A., and Binder W.J. Cosmetic uses of Botulinum neurotoxin A: An overview. Arch Facial Plast Surg 4 (2002) 214-220
26. Jongerius P.H., Rotteveel J.J., van Limbeek J., et al. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 63 (2004) 1371-1375
27. Parker J.F., Vats A., and Bauer G. EMLA toxicity after application for allergy skin testing. Pediatrics 113 (2004) 410-411
28. Li M., Goldberger B.A., and Hopkins C. Fatal case of BOTOX-related anaphylaxis?. J Forensic Sci 50 (2005) 169-172
29. Hussein I., Kershaw A.E., and Tahmassebi J.F. The management of drooling in children and patients with mental and physical disabilities: A literature review. Int J Pediatric Dent 8 (1998) 3-11
30. Dogu O., Apaydin D., Sevin S., et al. Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhea in patients with Parkinson's disease. Clin Neurol Neurosurg 106 (2004) 93-96
31. Friedman A., and Potulska A. Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism Relat Disord 7 (2001) 329-332
32. Guide for Reconstitution and Storage of Botox®. Allergan, Inc., Irvine, CA. www.botoxmedical.com Accessed October 31, 2008
33. Kazim N.A., and Black E.H. Botox: Shaken, not stirred. Ophthal Plast Reconstr Surg 24 (2008) 10-12
34. Jabor M.A., Kaushik R., Shayani P., et al. Efficacy of reconstituted and stored botulinum toxin type a: An electrophysiologic and visual study in the auricular muscle of the rabbit. Plast Reconstr Surg 111 (2003) 2419-2426
35. Hexsel D.M., DeAlmeida A.T., Rukowitsch M., et al. Multicenter, double blind study of the efficacy of injections with botulinum toxin type a reconstituted up to six consecutive weeks before application. Dermatol Surg 29 (2003) 523-529